Literature DB >> 10884283

Comparative analysis of lipid composition of normal and acute-phase high density lipoproteins.

W Pruzanski1, E Stefanski, F C de Beer, M C de Beer, A Ravandi, A Kuksis.   

Abstract

In the acute-phase response and in diseases with prolonged acute phases, normal HDL (NHDL) is converted into acute-phase HDL (APHDL) and becomes proinflammatory and unable to protect LDL against oxidative modification. Earlier work had demonstrated that these changes are associated with alterations in apolipoprotein composition and enzymatic activity of APHDL, but the effect of the acute-phase condition on the lipid composition of APHDL had remained obscure. The present study shows marked quantitative differences in lipid composition between NHDL and APHDL. Specifically, APHDL contained 25% less total lipid per milligram of protein. Up to 50% of cholesteryl ester in the lipid core of APHDL was replaced by triacylglycerol; however, the total phospholipid/total neutral lipid ratios were the same as in NHDL, both lipoproteins giving similar calculated lipid core radii. Furthermore, the phosphatidylcholine/sphingomyelin ratio in APHDL was nearly double that in NHDL, indicating a relative loss of sphingomyelin. A decrease was also seen in diacyl and alkenylacyl glycerophosphatidylethanolamine as well as in phosphatidylinositol of APHDL when compared with NHDL. APHDL contained proportionally more saturated and less polyunsaturated and isoprostane-containing species of phosphatidylcholine, as well as more saturated than unsaturated cholesteryl esters. APHDL also contained significantly more free fatty acids, lysophosphatidylcholine, and free cholesterol. These changes in the lipid composition of HDL are consistent with the alterations in the apoprotein composition and enzymatic activity of APHDL and indicate proinflammatory and proatherogenic roles for APHDL.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10884283

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  33 in total

1.  Role of HDL in cholesteryl ester metabolism of lipopolysaccharide-activated P388D1 macrophages.

Authors:  Sabrina Uda; Stefano Spolitu; Fabrizio Angius; Maria Collu; Simonetta Accossu; Sebastiano Banni; Elisabetta Murru; Francesca Sanna; Barbara Batetta
Journal:  J Lipid Res       Date:  2013-08-16       Impact factor: 5.922

2.  The HDL lipidome is widely remodeled by fast food versus Mediterranean diet in 4 days.

Authors:  Chenghao Zhu; Lisa Sawrey-Kubicek; Elizabeth Beals; Riley L Hughes; Chris H Rhodes; Romina Sacchi; Angela M Zivkovic
Journal:  Metabolomics       Date:  2019-08-17       Impact factor: 4.290

3.  Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity.

Authors:  Tomáš Vaisar; Chongren Tang; Ilona Babenko; Patrick Hutchins; Jake Wimberger; Anthony F Suffredini; Jay W Heinecke
Journal:  J Lipid Res       Date:  2015-05-20       Impact factor: 5.922

4.  High interleukin-6 plasma levels are associated with low HDL-C levels in community-dwelling older adults: the InChianti study.

Authors:  Giovanni Zuliani; Stefano Volpato; Alessando Blè; Stefania Bandinelli; Anna Maria Corsi; Fulvio Lauretani; Giuseppe Paolisso; Renato Fellin; Luigi Ferrucci
Journal:  Atherosclerosis       Date:  2006-06-19       Impact factor: 5.162

Review 5.  HDL lipids and insulin resistance.

Authors:  Andrew N Hoofnagle; Tomas Vaisar; Poulami Mitra; Alan Chait
Journal:  Curr Diab Rep       Date:  2010-02       Impact factor: 4.810

6.  Apolipoprotein A-I and serum amyloid A plasma levels are biomarkers of acute painful episodes in patients with sickle cell disease.

Authors:  Ashaunta Tumblin; Anitaben Tailor; Gerard T Hoehn; A Kyle Mack; Laurel Mendelsohn; Lita Freeman; Xiuli Xu; Alan T Remaley; Peter J Munson; Anthony F Suffredini; Gregory J Kato
Journal:  Haematologica       Date:  2010-04-07       Impact factor: 9.941

Review 7.  Unraveling the complexities of the HDL lipidome.

Authors:  Anatol Kontush; Marie Lhomme; M John Chapman
Journal:  J Lipid Res       Date:  2013-03-30       Impact factor: 5.922

8.  Hydrolysis of Phosphatidylcholine-Isoprostanes (PtdCho-IP) by Peripheral Human Group IIA, V and X Secretory Phospholipases A2 (sPLA2).

Authors:  Arnis Kuksis; Waldemar Pruzanski
Journal:  Lipids       Date:  2017-05-20       Impact factor: 1.880

Review 9.  G2A and LPC: regulatory functions in immunity.

Authors:  Janusz H Kabarowski
Journal:  Prostaglandins Other Lipid Mediat       Date:  2009-04-19       Impact factor: 3.072

Review 10.  Why is HDL functionally deficient in type 2 diabetes?

Authors:  Anatol Kontush; M John Chapman
Journal:  Curr Diab Rep       Date:  2008-02       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.